MedTrace Logo

Laser-assisted ICSI Versus Conventional ICSI

NCT03665103 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 966

Last updated 2019-08-07

No results posted yet for this study

Summary

Degeneration rate after ICSI is expectable but decreasing it is a goal. Laser-assisted ICSI can serve to decrease this degeneration rate.

Conditions

Interventions

OTHER

Laser-assisted ICSI

Laser opening of the zona pellucida.

Sponsors & Collaborators

  • Ibn Sina Hospital

    lead OTHER_GOV

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-17
Primary Completion
2019-08-01
Completion
2019-08-05

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03665103 on ClinicalTrials.gov